ABSTRACT
Objective: The purpose of this review is to define the feeling of loneliness within a couple while taking into consideration the factors that lead a person to feel lonely in a couple or in a romantic relationship. Our goal is to understand the effects of the feeling of loneliness on these individuals during the global health crisis brought on by COVID-19 and to take these factors into account in designing effective therapeutic care. The different manifestations of loneliness in a couple should also be highlighted. Method(s): We used the PRISMA methodology to select the relevant studies. The keywords ("Solitude" or "Loneliness") and ("Couple" or "Married" or "Partnership") allowed us to select 19 references dealing with the theme. We conducted searches of the following databases: "Cairn", "PsychInfo and Psycarticle", "PubMed and Medline", "ScienceDirect" and finally, "Web of Science" in order to find articles covering a ten-year period. Result(s): There are different definitions for the subjective experience of loneliness. The review of the literature highlights the fact that loneliness can lead to positive or negative psychological consequences (it can lead to the development of creative capacity or, on the contrary, result in depression in some cases). Attachment patterns have been shown to be the basis for the tolerance of feelings of loneliness. Indeed, an anxious attachment would encourage the couple to avoid the feeling of loneliness. According to the literature, this defensive mechanism of seeking presence in the couple would make it possible to limit the impact of loneliness. This solitude depends on the level of relational quality within the couple. A poor relational quality would lead to greater loneliness and would impact intimate relationships. Loneliness is supposedly not experienced in the same way by men and women: Men seem to be more protected by marriage while women's level of loneliness may be higher because of the household chores they have to do. Men and women would nevertheless remain subject to the phenomena of contamination, i.e., when one of the partners feels lonely, the other will also be lonely. However, it seems that marriage protects against feelings of loneliness and its negative consequences. Loneliness does not have only negative effects. It can be beneficial for developing creativity and finding oneself. The periods of confinement during the COVID-19 crisis provided people with an increase in the amount of time they didn't normally have on a daily basis. This may have been beneficial for some people and can be associated with positive emotions. Individuals who spent the lockdowns with others felt less alone and experienced less psychological distress. However, confinements did produce some negative effects on couples. The increased stress of the pandemic and the constant proximity led to an increase in spousal abuse. The consequences of confinement for couples whose relationships were already troubled resulted in frequent separation and/or divorce. The potential for conflict was related to limited financial resources, not working, and the significant risk of contracting SARS COV-2. Conclusion(s): The articles dealing with the feeling of loneliness that we reviewed presented quantitative methods to the detriment of qualitative aspects and focused largely on the negative aspects of the feeling of loneliness. Other academic disciplines, such as sociology, demonstrate a lack of understanding concerning what is at stake with the feeling of loneliness. The articles intersect and tend to highlight the attachment relationships that are formed in childhood as a determining factor in the feeling of solitude later in life. The quality of the relationship, gender, and marital status are also factors to be considered. Loneliness has a clear influence on the well-being of the relationship but it is not an individual characteristic of the relationship itself. It finally appears as an individual characteristic with an impact on the assessment of the quality of the relationship and on the appreciatio of the spouse.Copyright © 2023 Elsevier Masson SAS
ABSTRACT
The pandemic caused by the COVID-19 has influenced peoples' lifestyles. Home-confinement scenario might impair physical activity practice, resulting in new challenges for maintaining health during the pandemic of the COVID-19. The aim of this study was to present the current context of COVID-19 pandemic, its impact on the practice of physical activity, and the strategies available to remain active during home-confinement according to international recommendations. The narrative review was conducted based on studies that analyzed themes related to physical activity and COVID-19. Virtual Health Library (VHL), CINAHL, Cochrane, PsycINFO, PubMed, ScienceDirect, Scientific Electronic Library Online (SciELO), Scopus, SPORTDiscus, and Web of Science databases were searched for relevant papers. Although an increased number of experimental studies are still necessary, people should devote more time to physical activity during social isolation. Guidelines were adjusted by international entities in order to encourage people to remain active, through practice regular physical activity, using alternative strategies such as fitness program applications, exergames, online exercise classes, and even chores. Reduction of prolonged sedentary behavior could contribute to maintain health and improve quality of life during the COVID-19 pandemic.Copyright © Universidad Peruana Cayetano Heredia, Facultad de Medicina Alberto Hurtado. All Rights Reserved.
ABSTRACT
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2, which was first discovered in Wuhan, China. The disease has grown into a global pandemic causing mild to moderate symptoms in most people. The disease can also exhibit serious illnesses, especially for patients with other chronic diseases such as cardiovascular diseases, diabetes, chronic respiratory disease, or cancer. In such cases of severe illness, high flow nasal oxygen (HFNO) has been used to provide oxygenation to COVID-19 patients. However, the efficiency of HFNO remains uncertain, prompting the conduction of this systematic review to evaluate the effectiveness of the therapy. A thorough search for relevant and original articles was carried out on five electronic databases, including ScienceDirect, PubMed, Cochrane Library, Embase, and Google Scholar. No time limitation was placed during the search as it included all the articles related to COVID-19 from 2019 to 2022. The search strategy utilized in this systematic review yielded 504 articles, of which only 10 met the eligibility criteria and were included. Our meta-analysis reveals that HFNO success rate was higher than HFNO failure rates (0.52 (95% CI;0.47, 0.56) and 0.48 (95% CI;0.44, 0.53), respectively), however, the difference was statistically insignificant. HFNO was associated with a significant decrease in mortality and intubation rates (0.28 (95% CI;0.19, 0.39) and 0.28 (95% CI;0.18, 0.41), respectively). Our statistical analysis has shown that significantly lower ROX index (5.07 +/- 1.66, p = 0.028) and PaO2/FiO2 (100 +/- 27.51, p = 0.031) are associated with HFNO failure, while a significantly lower respiratory rate (RR) (23.17 +/- 4.167, p = 0.006) is associated with HFNO success. No statistically significant difference was observed in SpO2/FiO2 ratio between the HFNO success and failure groups (154.23 +/- 42.74 vs. 124.025 +/- 28.50, p = 0.62, respectively). Based on the results from our meta-analysis, the success or failure of HFNO in treating COVID-19 adult patients remains uncertain. However, HFNO has been shown to be an effective treatment in reducing mortality and intubation rates. Therefore, HFNO can be recommended for COVID-19 patients but with close monitoring and should be carried out by experienced healthcare workers.Copyright © 2023 The Authors
ABSTRACT
INTRODUCTION: Quoique la vaccination contre le COVID-19 a boulverse l'evolution generale de cette pandemie, mais plusieurs effets secondaires sont un sujet de discussion, et l'encephalite aigue en fait partie. MATERIELS ET METHODES: Ce travail a pour objectif de realiser une revue systematique des cas rapportes dans la litterature dans les grandes bases de donnees (PUBMED-EMBASSE-SCIENCE DIRECT), dans le but de connaitre les caracteristiques demohgraphiques, imageriques et pronostiques de ces patients. RESULTAS: 7 cas sont inclus dans notre revue dont 5 sont des femmes, la moyenne d'age est a 54.65, 3 types de vaccins sont rapportes, mRNA1273 chez 3 patients, ChAdOx1 chez 3 patients et BNT162b2 mRNA chez un seul. La moyenne d'appartitio ndes symptomes est 6.67jours apres la premiere dose. Le signe neurologique commun est la confusion avec les troubles de la vigilance. Le bilan etiologie initiale est negative chez tous les patients. IRM est realisee chez tous les patients, et l'aspect le plus frequent ete les lesions d'hypersignal de la substance blance en sequence T2 flair, qui predominait surtout au niveau de la region temporal chez 4 patients (Figure 1), et au niveau du pons chez 2 malades. EEG est realise chez 6 des patients a montre un rythme theta diffus. Apres la corticotehrapie systemique, l'evolution ete favorable chez 6 patients. DISCUSSION: L'encephalite aigue est generalement secondarie a une infection ou l'origine auto-immune, qui contribuent a environ trois quarts des cas diagnostiques. La vaccination anti-COVID-19 peut etre associee dans des tres rares cas a des complications neurologiques, telles que l'encephalite aigue. Jusqu'au Juin 2022, 7 cas sont rapportes dans la litterature1, ceci peut etre expliquee par une reponse inflammatoire innaproriee2, comme celle observee lors de l'encephalite auto-imune. CONCLUSION(S): Les medecins doivent etre attentifs a l'encephalite apres la vaccination afin de garantir une issue favorable.Copyright © 2023
ABSTRACT
Background: COVID-19 has had a huge impact on women's health. Physical, mental, and psychological effects are a small part of the effects of COVID-19 on women. Menstrual disorders are also a significant complication of COVID-19 in women and girls. This study was performed as a review to investigate the effects of Covid-19 on the menstrual cycle in women. Method(s): In this study, by using the Keywords COVID-19, women, AND menstruation, databases such as Google Scholar, SID, PubMed, and Science Direct were searched and several studies were reviewed. Result(s): Heavy, light menstruation, irregular periods, and missed periods are some of the COVID-19 effects on women. However, the side effects are short-term and go away about one to two months after getting infected. The effects of the COVID-19 vaccine are almost the same as those gotten infected by COVID-19. Astra-Zeneca and Pfizer vaccines had the most symptoms and caused menstrual disorders compared to other types of vaccines. Conclusion(s): Women and girls make up a large portion of society. Hence, it is recommended that health planners and policymakers make efforts to improve their physical and mental health by focusing on women's health and solving their problems. Menstrual disorders were short-term, but in women who had many problems for more than two months, it is recommended to see a specialist and a doctor.
ABSTRACT
The novel coronavirus (SARS-CoV-2), which was isolated in January 2020, emerged as a result of natural evolution and has already infected millions of people around the world due to its extensive human-to-human transmission capacity. Highlighting the clinical manifestations, pathology and immune response against the SARS-CoV-2 infection process, this review study was con-ducted through a comprehensive bibliographic search of academic papers that are available online at the following databases Science Direct, Pub Med, ACS Publications, Nature, BioRxiv and Me-dRxiv. According to the analyzed works, people infected with SARS-CoV-2 may display fever and dry cough as the main clinical symptoms and they may also present breathing difficulty, muscle pain (myalgia), chills, lack of appetite, fatigue, sore throat, altered consciousness, diarrhea, vomit-ing, nasal discharge and syncope. When considering the immune status of patients with COVID-19, it is highlighted that hypercytokinemia contributes to the severity that can even result in death. Lymphopenia is the most frequent prognosis described in cases of COVID-19. Thus, a de-tailed understanding of the specific inflammatory pathways that result in the pathology of COVID-19 is crucial for the immediate development of clinical therapeutic approaches.Copyright © 2021 Bentham Science Publishers.
ABSTRACT
Background: Severe viral pneumonia cases were observed in the people of Wuhan, China in December 2019. It has already affected almost every country around the globe and was declared a pandemic by the World Health Organization. We aim to evaluate the therapeutics and safety of various off label COVID-19 drugs. Method(s): PubMed, Research Gate, Science Direct, Google Scholar, Centre for Disease control and prevention (CDC) portal, Chinese Centre for Disease Control and prevention (CCDC) portal, World Health Organization (WHO) portal were searched for obtaining reliable data. Result(s): COVID-19 is creating a storm of deaths and active cases globally, which is forcing the pharmaceutical companies and scientists to work day and night to find an effective and safer anti-COVID-19 medication. Various in vitro and clinical trials had been performed as well as are currently ongoing to analyze the mechanisms and therapeutics of off label medications like Chloroquine, Hydroxychloro-quine, Amodiaquine, Azithromycin, Remdesivir, Favipiravir, Ritonavir/Lopinavir, Umifenovir, Osel-tamivir, Ribavirin, Nafamostat, Camostat, Tocilizumab, Ivermectin, Nitazoxanide, Famotidine, Vitamin D, Corticosteroids and Dexamethasone. In vitro studies were performed by utilizing Vero E6 cells and hSLAM cells while open/closed, randomized/non-randomized, single-centered/multi-centered and retrospective clinical trials and case studies were organized to determine their safety and efficacy. Conclusion(s): Although these drugs have shown promising results against COVID-19 patients, it cannot be concluded that these drugs are truly safe and effective because there are no conclusive evidence to support the facts since only limited researches and studies had been investigated.Copyright © 2021 Bentham Science Publishers.
ABSTRACT
Countries in sub-Saharan Africa (SSA) are expected to experience more public health emergencies (PHEs) in the near future. The fragile health systems emanating from poor health governance, inadequate health infrastructure, shortage of healthcare workers (HCWs), inadequate essential medicines and technology, and limited funding will make responses to these outbreaks slow and ineffective as seen with the COVID-19 pandemic. The workload for HCWs will grow due to these PHEs, which will increase the likelihood that they may experience burnout. This narrative review loosely followed the guidelines provided in the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocols (PRISMA-P) statement. Google Scholar, PubMed, and ScienceDirect databases were used to retrieve relevant articles. Two reviewers assessed the titles and abstracts of all identified articles and extracted the data independently and compared their results thereafter. The causes of burnout among HCWs, its impact on patients, HCWs, and healthcare institutions, as well as preventive steps that should be taken to safeguard HCWs from burnout, are all covered in this article.Copyright © 2023 The Author(s)
ABSTRACT
Introduction: The elderly more than others in the society were affected by the corona epidemic. Social isolation as one of the important consequences of corona pandemic, affected the elderly. This review study was performed with aim to investigate studies related to social isolation of the elderly during the corona virus epidemic. Method(s): In this systematic review, to find the article entitled elderly social isolation and Covid-19, the articles published in English from the beginning of the Corona virus pandemic to 2021 were searched in databases of Scopus, ISI (web of science), PubMed (Medline), Cochrane Library, and Science direct using MeSH and the keywords of "social isolation", "elderly", "loneliness", "coronavirus", "COVID -19", "SARS COVID -2", "pandemic", "elderly", alone and in combination using the operators AND and OR. Result(s): A total of 11 studies related to Covid-19 and social isolation were included in the study. The findings showed that the COVID-19 pandemic and health policies have exacerbated feelings of loneliness and isolation in the elderly. Loneliness and social isolation in the elderly have increased due to the implementation of preventive protocols such as social distance and quarantine. Conclusion(s): Attention to approaches which reduce social isolation in the elderly during the COVID-19 pandemic is one of the important interventions that should be considered by government and policy makers to reduce the rate of harm in the elderly and consequently reduce health costs to compensate its side-affects.Copyright © 2023, Mashhad University of Medical Sciences. All rights reserved.
ABSTRACT
Introduction: The elderly more than others in the society were affected by the corona epidemic. Social isolation as one of the important consequences of corona pandemic, affected the elderly. This review study was performed with aim to investigate studies related to social isolation of the elderly during the corona virus epidemic. Method(s): In this systematic review, to find the article entitled elderly social isolation and Covid-19, the articles published in English from the beginning of the Corona virus pandemic to 2021 were searched in databases of Scopus, ISI (web of science), PubMed (Medline), Cochrane Library, and Science direct using MeSH and the keywords of "social isolation", "elderly", "loneliness", "coronavirus", "COVID -19", "SARS COVID -2", "pandemic", "elderly", alone and in combination using the operators AND and OR. Result(s): A total of 11 studies related to Covid-19 and social isolation were included in the study. The findings showed that the COVID-19 pandemic and health policies have exacerbated feelings of loneliness and isolation in the elderly. Loneliness and social isolation in the elderly have increased due to the implementation of preventive protocols such as social distance and quarantine. Conclusion(s): Attention to approaches which reduce social isolation in the elderly during the COVID-19 pandemic is one of the important interventions that should be considered by government and policy makers to reduce the rate of harm in the elderly and consequently reduce health costs to compensate its side-affects.Copyright © 2023, Mashhad University of Medical Sciences. All rights reserved.
ABSTRACT
The emergence of new pathogenic viruses and the constant outbreak of viral diseases have created an upsurge in novel antiviral agents. Marine natural products are the most unexplored reservoir of novel, biologically active, chemically diverse compounds. A systematic literature review was conducted using PRISMA guidelines, accessing four major databases;PubMed, Science Direct, Scopus, and Google Scholar. Numerous studies supported the robust antiviral activity of marine resources against drug-resistant viruses such as SARS, Ebola, Influenza, and HIV. However, adequate research on marine resources for developing anti-covid therapy is lacking. The aim of the review was to explore the marine resources and their compounds that could lead to developing an effective antiviral drug. We also highlighted the current status of novel compounds against different species of corona family and discussed the future prospects of marine resources against COVID-19 management.Copyright © 2023 the authors.
ABSTRACT
Introduction: The food security and nutrition of individuals was affected due to the coronavirus (COVID-19) pandemic. Increased food insecurity limits individuals from having a full and dignified quality of life. Objective(s): To assess the access and availability of food security in the Mexican population affected by the COVID-19 pandemic in Mexico through a literature review. Methodology: Literature review in databases such as: PubMed, Science Direct, Scielo, FAO, UN, ENSANUT, Salud Publica de Mexico and CONACYT. The search for information was carried out from November 2021 to May 2022, considering articles published from March 2020 and in relation to the health contingency period. A search equation was used for the search and, in addition, the methodological evaluation of Munns et al. was applied. Articles in Spanish and English were included, with content referring to Mexico. Result(s): A total of 274 articles were identified in databases;based on the eligibility criteria, surveys and/or articles on nutrition, food security and lifestyle during the pandemic in Mexico were considered. Articles were excluded for having another study design (2), title (100), abstract (82), non-relevant information (54) and (9) for full text, because they did not meet the proposed characteristics. Finally, 10 articles were selected for the literature review. With this, the data showed that the COVID-19 pandemic caused diverse affectations in the Mexican territory, this was evidenced after an increase in food insecurity and changes in lifestyle. Conclusion(s): Food security and nutrition of individuals were affected in the Mexican population, due to economic issues, changes in dietary patterns, as well as job losses and loss of income.Copyright © 2022 Asociacion Espanola de Dietistas-Nutricionistas. All rights reserved.
ABSTRACT
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is named as the coronavirus disease of 2019 (COVID-19). Patients with SARS-CoV-2 infection experience a wide range of symptoms and they are at the risk of various systemic complications. Besides the pulmonary complications, COVID-19 cases may develop cardiovascular and hematological complications. This study aimed to review the most important hematological and cardiovascular complications caused by SARS-CoV-2 infection. Method(s): The English databases, including Pubmed, ScienceDirect, Cochrane Library, Scopus, and Google Scholar, were searched. The published papers were selected and reviewed based on the subject of this study. Result(s): The review of the literature showed that several cardiovascular complications related to COVID-19, including acute myocardial infarction, cardiomyopathy, acute heart failure, and venous thromboembolic events due to coagulation abnormalities, have been reported. COVID-19 associated hematological complications include elevated levels of hematological factors including C-reactive pro-tein, lactate dehydrogenase, procalcitonin, and ferritin. Furthermore, the levels of blood cells, including lymphocytes and thrombocytes, can be reduced. Conclusion(s): This study reviewed COVID-19-associated cardiovascular and hematopoietic complica-tions. In conclusion, the patients may experience a wide range of cardiovascular and hematological is-sues during the illness. These complications are often associated with the need for ICU support and care which imposes further costs to the healthcare system. So the healthcare team must consider the possible complications when treating COVID-19 patients to reduce the treatment costs and mortality of patients.Copyright © 2021 Bentham Science Publishers.
ABSTRACT
Background: Coronavirus disease 2019 (COVID-19) was originated first in Wuhan, Chi-na, in December 2019, and it is known to be caused by severe acute respiratory syndrome coron-avirus-2 (SARS CoV-2). The management of COVID-19 could be achieved by means of the usage of the repurposed drugs, inhibiting the viral entry and/or viral fusion such as umifenovir, Barici-tinib, Camostat mesylate, Nafamostat mesylate, and the drugs blocking the viral replication, which include favipiravir, remdesivir, Lopinavir/ritonavir, Ribavirin, Sofosbuvir, chloroquine and Hydrox-ychloroquine. Objective(s): Along with the drugs that target the SARS-CoV-2 virus, adjunctive therapies are also employed. This review focuses on the adjuvant therapies employed to manage the COVID-19-asso-ciated complications, such as cytokine storm, acute respiratory distress syndrome (ARDS), respiratory failure, cardiac injury, coagulopathy, and multi-organ failure. Method(s): The literature was searched in databases such as Medline/PubMed Central/PubMed, Goo-gle Scholar, Science Direct, EBSCO, Scopus, EMBASE, Directory of open access journals (DOA-J), and reference lists to identify relevant articles. Result(s): Various studies have been identified for the use of corticosteroids, interferons, monoclon-al antibodies, etoposide, ruxolitinib, anticoagulants, convalescent plasma, immunoglobulins, mes-enchymal stem cells, natural killer (NK) cells, and inhaled nitric oxide (NO) as adjuvant therapy to manage the patients with COVID-19 along with the repurposed drugs targeting SARS-CoV-2. Conclusion(s): The safety and efficacy of adjuvant therapy are needed to be confirmed by various ongoing randomized controlled clinical trials.Copyright © 2021 Bentham Science Publishers.
ABSTRACT
Background: The world is presently experiencing the devastating pandemic by a coronavirus that compelled the whole research communities to relook the epidemiology of these viruses, particularly their evolution and transmission in the milieu of the human-animal interface. Method(s): The data from various databases like Science Direct, PubMed, Elsevier, Scopus, and Nature has been referred to classify the virus, its epidemiology, zoonotic potential, and its host determinants. The literature survey started when COVID-19 was declared as a pandemic by the WHO. Results and Conclusion(s): In this review article, we discuss the paradigm of coronaviruses as a new emerging zoonotic disease. We also examine the zoonotic concerns of these viruses in the setting of interspecies transmission and their consequences. These critical findings might be helpful for researchers to understand the mechanism of these viruses and the diseases they caused.Copyright © 2021 Bentham Science Publishers.
ABSTRACT
Since the outbreak in December 2019, in Wuhan (China) of COVID-19, approved drugs are still lacking and the world is seeking effective treatment. The purpose of this article is to review the medicinal plants with potential to be used as complementary therapies against COVID-19. Bibliographic information was searched in several databases (Google Scholar, PubMed, Scopus, ScienceDirect, PROTA, ResearchGate and GLOBEinMED), to retrieve relevant papers on (1) plants used to manage common symptoms of COVID-19, (2) plant secondary metabolites with confirmed inhibitory effects on COVID-19 and (3) plants exhibiting pharmacological activities of relevance for COVID-19 management. A total of 230 species was recorded as potential source of ingredients for the fight against the 2019 novel corona virus. Of these species, 30 contain confirmed antiCOVID-19 secondary metabolites, 90 are used traditionally to manage at least 3 common symptoms of COVID-19, 10 have immunostimulant activity, 52 have anti-inflamatory activity, 14 have antiviral properties and 78 species are documented as used to treat malaria. A PCA analysis showing cluster formatting among the recorded species indicates 4 groups of species and an array of possibility of using individual species or a combination of species for their complementary effects. The authors argue that Cameroonian medicinal plants can be of potential contribution to the fight against COVID-19. Further applied research is needed to provide more scientific evidence for their efficacy, to establish standard formulations and clinical studies as part of efforts to develop therapies for COVID-19.Copyright © 2021, Institute of Korean Medicine, Kyung Hee University.
ABSTRACT
Background: Evidence reveals that COVID-19, in addition to impacting the respiratory system, affects other organs, including the male and female reproductive systems. The purpose of this study was to examine the impact of COVID-19 on the human reproductive system. Method(s): Data were collected in SID, Science Direct, PubMed, and Google Scholar databases. The Keywords including COVID- 19, reproductive system, fertility, and factors related to mesh term utilization and Boolean strategy were used. Papers from 2019 to 2022 were extracted. Finally, out of 58 searched articles, 20 articles related to the purpose of the study were reviewed. Result(s): The results were organized into two categories. The first category deals with the effect of COVID-19 on the female reproductive system including Sleep disorders following quarantine on gonadotropin release and its effect on the ovaries and menstrual cycle, preterm delivery, increased cesarean delivery, the possibility of intrauterine infection of the fetus and dysfunction of the reproductive glands. The second category concerns the effect of COVID-19 on the male reproductive system including abnormal semen quality, possible effect on gonocyte differentiation in the early stages of spermatogenesis, negative effect on spermatogenesis, testicular dysfunction, and changes in testosterone concentration by increasing serum LH, testicular inflammation, decreased sperm concentration in semen, impaired sperm motility, dysfunction of the reproductive glands, significant damage to the seminiferous tube, swelling of Sertoli cells, decreased Leydig cells, significant disorder on semen volume and impaired sperm morphology. Conclusion(s): The findings revealed that COVID-19 has an impact on various aspects of the human reproductive system. Midwives and gynecologists should alleviate couples' fears about infertility by recognizing these cases and offering suitable counseling to couples infected with COVID-19.
ABSTRACT
Background: COVID-19 is a new, health-threatening infectious disease in the world in 2020 and is caused by a novel coronavirus SARS-CoV-2. As of July 13, 2020, 4,881,579 active cases of COVID-19 were diagnosed, and 571,080 deaths were reported globally. In India, 301,850 active cases and 23,187 deaths were reported. To date, no effective treatment is available against the deadly virus SARS-CoV-2. Drug manufacturers, institutional laboratories, and other organizations have started developing vaccines to combat COVID-19 infection. Method(s): Science Direct, Elsevier, PubMed, Scopus, and Nature databases were referred to know the current scenario of the disease. Moreover, recent data have been obtained from the World Health Orga-nization, Centre of Disease Control, case studies, newspapers, and Worldometer reports. Data of Vaccine Centre at the London School of Hygiene & Tropical Medicine, Clinicaltrials.gov, and US National Library of Medicine have also been accessed to obtain the latest information about ongoing clinical tri-als. Result(s): The primary source of the SARS-CoV-2 outbreak is connected to the Hunan seafood and live animal market in Wuhan city, Hubei Province, China. Like;SARS-CoV, and MERS-CoV, SARS-CoV-2 is also a zoonotic virus affecting the lower respiratory tract in humans. The pathogenesis of COVID-19 involves attachment of its Spike (S) protein to the angiotensin-converting enzyme 2 (ACE2) receptor in the lower respiratory tract in humans. The most common symptoms of COVID-19 are fever, cough, sore throat, fatigue, headache, myalgia, septic shock, and breathlessness. Few patients with COVID-19 infection experience diarrhea, vomiting, and abdominal pain. Currently, FDA approved drugs being used to treat COVID-19. Conclusion(s): This review article presents the importance of traditional Indian herbs recommended by AYUSH as precautionary and curative measures of COVID-19 until vaccines and drugs are made avail-able. Moreover, this article discussed the origin, symptoms, mode of transmission, management, and diagnostics techniques for the detection of the SARS-CoV-2 virus.Copyright © 2021 Bentham Science Publishers.
ABSTRACT
Background: In December 2019, a large number of patients with a novel coronavirus were identified in Wuhan, China. The novel coronavirus (COVID-19) is highly contagious and in-creasing the rate of mortality day by day. The World Health Organization declared COVID-19 as a worldwide pandemic on March 11, 2020. Early diagnosis of SARS-CoV-2 can restrict the COVID-19 pandemic. Objective(s): We aim to study the currently available diagnostic methods for COVID-19. Method(s): World Health Organisation portal, Centre for Disease Control and Prevention portal, Indian Council of Medical Research portal, Chinese Centre for Disease Control and Prevention por-tal, Science Direct, Google Scholar, Research Gate, etc. were searched for obtaining data. Result(s): Rapid diagnosis and prompt treatment can reduce the number of prospective cases. The diagnostic strategy encompasses the screening of the virus with nucleic acid amplification test (NAAT) such as real-time reverse-transcription polymerase chain reaction (RT-PCR) assays. Sero-logical testing is a diagnostic procedure used for identifying the presence of immune responses. Radiological findings in individuals with COVID-19 are characterised by multiple areas of consolida-tion in the chest. Rapid antigen tests are in-vitro diagnostics that have been designed to give results within 10-20 min. Conclusion(s): Rapid, simple, and safe diagnosis of COVID-19 has a great impact on deciding clinical and epidemiological factors. RT-PCR results often require 5 to 6 hours. Diagnosis by serologi-cal testing is not suitable but important epidemiologically. At present, the best radiological strategy remains undefined. Rapid antigen tests have limitations on sensitivity.Copyright © 2021 Bentham Science Publishers.
ABSTRACT
Background: COVID-19 is an infectious disease caused by SARS-CoV-2. The disease has hit hard around the globe and is now a pandemic. As of April 01, 2020, a total of 875,560 cases have been reported and the figures are increasing day by day. Currently, there is no treatment or vaccine available for curing COVID-19 and pharmaceutical companies are racing toward the common goal of achieving the cure. Method(s): Scientific databases, including Science direct, Pub med, Elsevier, Scopus, and Nature, were explored. Data has also been accessed from case reports, newspaper reports, internet data, World Health Organisation (WHO) reports, and Centre of Disease Control (CDCs) reports. The US National Library of Medicine, Clinicaltrials.gov, were accessed to get information about the ongoing clinical trials. The literature survey started in the first week of February 2020 and was completed in the first week of April 2020. Additional literature survey was done in the second week of June 2020. Result(s): The epicentre of COVID-19 is Wuhan City, Hubei Province, China. Coronavirus belongs to Order Nidovirale and is subdivided into four groups alpha, beta, gamma, and delta. Coronavirus 229E, NL63, HKU1, MERS-CoV and SARS-CoV are known to infect humans. It is an enveloped, non-segmented positive-sense RNA virus of size 30-32 kb with several structural and accessory proteins. The pathogenesis of COVID-19 involves attachment of Spike (S) protein of SARS-CoV-2 to the angio-tensin-converting enzyme 2(ACE2) receptor present on the host cell membrane. Clinical manifestation of COVID-19 include fever, cough, complicated dyspnoea, pneumonia, etc. Real-time-PCR is a sensi-tive test for the detection of SARS-CoV. Remdesivir, Bevacizumab, Darunavir and cobicistat, lopinavir-ritonavir, Oseltamavir, hydroxychloroquine, Sarilumab, mRNA-1273, Ad5-nCoV are some of the drugs under the clinical phase of the trial. People with A-positive blood group, with comorbidities like diabe-tes, hypertension, chronic pulmonary obstructive disease, substance abuse disorders, immunocom-promised individuals, health care workers, and older adults are at high risk of getting infected with SARS-CoV-2 Conclusion(s): This article gives insight into the occurrence of COVID-19, classification and structure of SARS-CoV-2, pathogenesis, pathological findings, clinical manifestation, diagnosis, potential treatment options and prevention, and people at risk of COVID-19.Copyright © 2021 Bentham Science Publishers.